3-氨基喹喔啉-2-甲酰胺 | 67568-30-3

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 二氮杂萘
• 中文名称: 3-氨基喹喔啉-2-甲酰胺
• 英文名称: 2-Amino-3-carboxamidoquinoxaline
• 英文别名: 2-aminoquinoxaline-3-carboxamide；3-amino-2-quinoxalinecarboxamide；3-amino-quinoxaline-2-carboxylic acid amide；3-Amino-chinoxalin-2-carbonsaeure-amid；3-Aminoquinoxaline-2-carboxylic acid amide；3-aminoquinoxaline-2-carboxamide
• CAS: 67568-30-3
• 化学式: C₉H₈N₄O
• mdl: MFCD02091223
• 分子量: 188.189
• InChiKey: VLZNCHUOPLEEDT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.6
• 重原子数：
  14
• 可旋转键数：
  1
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  94.9
• 氢给体数：
  2
• 氢受体数：
  4

安全信息

• 海关编码：
  2933990090

反应信息

• 作为反应物：
  描述：

  3-氨基喹喔啉-2-甲酰胺 在 sodium ethanolate 作用下， 以 乙醇 为溶剂， 反应 90.17h， 生成 2-(β-Diethylaminoethyl)carboxamido-4-oxo-3,4-dihydrobenzopteridine
  参考文献：
  名称：

  Synthesis and properties of 4-0x0-3,4-dihydrobenzo[g]pteridine-2-carboxylic acid and its derivatives

  摘要：

  DOI：

  10.1007/bf00766905
• 作为产物：
  描述：

  methyl 3-chloroquinoxaline-2-carboxylate 在 氨 作用下， 以 水 为溶剂， 生成 3-氨基喹喔啉-2-甲酰胺
  参考文献：
  名称：

  KINESIN INHIBITORS

  摘要：

  这项发明涉及下面所示的化合物(I)。公式(I)中的每个变量在规范中有定义。这些化合物可用于治疗由动力蛋白Eg5介导的疾病。

  公开号：

  US20080292626A1

文献信息

• Compositions of matter having bioactive properties
  申请人：Schmitz, Robert A.

  公开号：EP1288238A1

  公开（公告）日：2003-03-05

  Particles of coordinated complex comprising a basic, hydrous polymer and a capacitance adding compound, as well as methods for their production, are described. These complexes exhibit a high degree of bioactivity making them suitable for a broad range of applications through their incorporation into conventional vehicles benefiting from antimicrobial and similar properties.

  描述了由基础水合聚合物和电容添加化合物组成的协调复合物的颗粒，以及它们的生产方法。这些复合物表现出很高的生物活性，使它们适用于广泛的应用领域，通过将它们纳入传统载体中，从而受益于抗菌和类似性能。
• 3-Amino-2-quinoxalinecarbonitrile. New fused quinoxalines with potential cytotoxic activity
  作者：A. Monge、J. A. Palop、A. Piñol、F. J. Martínez-Crespo、S. Narro、M. González、Y. Sáinz、A. López De Ceráin、E. Hamilton、A. J. Barker

  DOI：10.1002/jhet.5570310506

  日期：1994.9

  Starting with 3-amino-2-quinoxalinecarbonitrile 1,4-dioxide 1, a new series of quinoxaline derivatives was prepared through chemical modifications of the 2-cyano and 3-amino groups. Nitration of 3-amino-2-quin-oxalinecarbonitrile 3 afforded the 7-nitro derivative 6. Diazotation of 3 gave the 3-chloro compound 9. 2,3-Quinoxalinedicarbonitrile 14 was obtained from 9. Pyridazino[4,5-b]quinoxalines 15 and 16

  从3-氨基-2-喹喔啉腈1,4-二氧化物1开始，通过化学修饰2-氰基和3-氨基制备了一系列新的喹喔啉衍生物。硝化3-氨基-2-喹喔啉腈3，得到7-硝基衍生物6。3的重氮化得到3-氯化合物9。从9获得2，3-喹喔啉二甲腈14。吡啶并[4,5- b ]喹喔啉15和16是通过将14与水合肼缩合而制备的。三唑并[4,5- b ]喹喔啉18，鉴定出异噻唑并[4，5- b ]喹喔啉20和两个吡唑并[3，4- b ]喹喔啉21和22。测试了化合物在有氧和低氧细胞中的细胞毒性作用。
• Novel imidazoquinoxalines
  申请人：Roussel Uclaf

  公开号：US04254123A1

  公开（公告）日：1981-03-03

  Novel imidazoquinoxalines of the formula ##STR1## wherein R is selected from the group consisting of hydrogen, alkyl of 1 to 5 carbon atoms, --NH.sub.4, alkali metal, alkaline earth metal, magnesium, aluminum and non-toxic, pharmaceutically acceptable amines, X is selected from the group consisting of hydrogen, alkoxy of 1 to 5 carbon atoms and carbamoyl and Y and Z are individually selected from the group consisting of hydrogen and halogen and their non-toxic, pharmaceutically acceptable acid addition salts having anti-allergic activity and their preparation.

  式子为##STR1##的新型咪唑喹啉化合物，其中R选择从氢、1至5个碳原子的烷基、--NH.sub.4、碱金属、碱土金属、镁、铝和无毒、药学上可接受的胺类中选取，X选择从氢、1至5个碳原子的烷氧基和氨基甲酰中选取，Y和Z分别从氢和卤素中选取，以及它们的无毒、药学上可接受的酸盐，具有抗过敏活性，以及它们的制备方法。
• AMINO-QUINOXALINE AND AMINO-QUINOLINE COMPOUNDS FOR USE AS ADENOSINE A2a RECEPTOR ANTAGONISTS
  申请人：Harris Joel M.

  公开号：US20110105513A1

  公开（公告）日：2011-05-05

  Compounds of the Formula (I), where W represents CH or N; and Q represents —CN, —C(═NOH)NH 2 , —CONHR 1 or various herein described heterocyclic radicals; as well as pharmaceutically acceptable salts, solvates, esters and prodrugs thereof. Care adenosine A 2a receptor antagonists and, therefore, are useful in the treatment of central nervous system diseases, in particular Parkinson's disease.

  化合物的公式（I），其中W代表CH或N; Q代表—CN、—C(═NOH)NH2、—CONHR1或各种在此描述的杂环基团; 以及其药学上可接受的盐、溶剂化物、酯和前药。这些化合物是腺苷A2A受体拮抗剂，因此在中枢神经系统疾病，特别是帕金森病的治疗中是有用的。
• Synthesis and oral antiallergic activity of carboxylic acids derived from imidazo[2,1-c][1,4]benzoxazines, imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles
  作者：Ian R. Ager、Alan C. Barnes、Geoffrey W. Danswan、Peter W. Hairsine、David P. Kay、Peter D. Kennewell、Saroop S. Matharu、Peter Miller、Peter Robson

  DOI：10.1021/jm00401a009

  日期：1988.6

  4H-Imidazo[2,1-c][1,4]benzoxazine-2-carboxylic acid (3) was found to possess potent activity in the IgE-induced rat passive cutaneous anaphylaxis model which may be predictive of clinical antiallergic activity. Compared to disodium cromoglycate (DSCG, 1), 3 was less active following iv administration but unlike DSCG showed very significant oral activity. To explore the structural requirements for this activity, a range of tricyclic compounds was prepared and their activities were measured. Individual 2-carboxylic acids derived from imidazo[1,2-a]quinolines, imidazo[1,2-a]quinoxalines, imidazo[1,2-a]quinoxalinones, pyrrolo[1,2-a]quinoxalinones, pyrrolo[2,3-a]quinoxalinones, and imidazo[2,1-b]benzothiazoles showed iv activities up to 10(3) times as potent as DSCG and many of them showed significant oral activity. From these, imidazo[1,2-a]quinoxaline-2-carboxylic acid 114 has been chosen for further development.